SINGAPORE & SAN DIEGO, Jan 29 (Bernama-BUSINESS WIRE) — ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced the formation of its Scientific Advisory Board (SAB). The SAB is composed of leading scientists in immunology and oncology who will help to guide ImmunoScape’s scientific strategy.
ImmunoScape’s Deep Immunomics platform enables the characterization of a patient’s immunome at ultra-high resolution. This technology reveals the immune system in action by directly observing the modulation of phenotype, function, and specificity of individual immune cells, at scale and over time. These insights can be provided to leading biopharma and academic partners to aid drug development efforts within multiple therapeutic areas, including immuno-oncology, infectious disease, and autoimmune disease.